Header Logo

STEPHEN PAPPAS

Concepts (64)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatorenal Syndrome
11
2023
32
2.570
 Why?
Vasoconstrictor Agents
10
2023
146
1.010
 Why?
Lypressin
8
2023
17
0.740
 Why?
Hepatitis B
1
2021
173
0.650
 Why?
Duty to Warn
1
2019
2
0.620
 Why?
Professional Impairment
1
2019
3
0.620
 Why?
Alcoholic Intoxication
1
2019
11
0.610
 Why?
Confidentiality
1
2019
106
0.580
 Why?
Hepatitis C Antibodies
1
2017
24
0.560
 Why?
Kidney Function Tests
2
2017
137
0.560
 Why?
Alcoholism
1
2019
253
0.500
 Why?
Diagnostic Tests, Routine
1
2017
134
0.500
 Why?
Hepacivirus
1
2017
273
0.490
 Why?
Albumins
6
2023
99
0.450
 Why?
Liver Cirrhosis
5
2023
947
0.240
 Why?
Liver Transplantation
3
2023
1128
0.210
 Why?
Respiratory Insufficiency
2
2022
239
0.200
 Why?
Hepatitis, Alcoholic
1
2023
34
0.190
 Why?
Hepatitis B Antibodies
1
2021
24
0.180
 Why?
Hepatitis B Vaccines
1
2021
45
0.180
 Why?
Acute-On-Chronic Liver Failure
1
2022
80
0.170
 Why?
Hepatitis B virus
1
2021
142
0.170
 Why?
Liver Cirrhosis, Alcoholic
1
2019
41
0.150
 Why?
Safety
1
2019
217
0.140
 Why?
Hepatic Encephalopathy
1
2019
94
0.140
 Why?
Drug Therapy
1
2017
94
0.130
 Why?
Health Personnel
1
2021
541
0.130
 Why?
Alcohol Drinking
1
2019
387
0.120
 Why?
Humans
15
2023
134156
0.120
 Why?
Self Report
1
2019
553
0.120
 Why?
Patient Education as Topic
1
2019
469
0.120
 Why?
Surgical Procedures, Operative
1
2017
191
0.120
 Why?
Interdisciplinary Communication
1
2016
135
0.110
 Why?
Systemic Inflammatory Response Syndrome
1
2016
198
0.110
 Why?
Interprofessional Relations
1
2016
157
0.110
 Why?
Information Dissemination
1
2016
199
0.100
 Why?
Hepatitis C
1
2017
389
0.100
 Why?
Metabolomics
1
2017
470
0.100
 Why?
Acute Kidney Injury
1
2020
704
0.100
 Why?
Gastrointestinal Diseases
1
2016
362
0.090
 Why?
Disease Progression
1
2017
2266
0.090
 Why?
Renal Replacement Therapy
2
2023
157
0.090
 Why?
Treatment Outcome
6
2023
13074
0.080
 Why?
Biomarkers
1
2019
3434
0.080
 Why?
Physicians
1
2016
639
0.080
 Why?
Double-Blind Method
2
2021
1665
0.060
 Why?
Canada
2
2016
346
0.060
 Why?
Drug Therapy, Combination
2
2017
1200
0.050
 Why?
Middle Aged
5
2021
29399
0.040
 Why?
Infusions, Intravenous
1
2021
572
0.040
 Why?
Combined Modality Therapy
1
2021
1310
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2017
76
0.030
 Why?
Placebos
1
2016
240
0.030
 Why?
Male
5
2021
66127
0.030
 Why?
Survival Rate
1
2020
2218
0.030
 Why?
Female
5
2021
71928
0.030
 Why?
Survival Analysis
1
2016
1599
0.020
 Why?
Randomized Controlled Trials as Topic
1
2017
1218
0.020
 Why?
Prognosis
1
2020
5086
0.020
 Why?
Aged
2
2020
21775
0.020
 Why?
Kidney
1
2016
1421
0.020
 Why?
Adult
2
2017
31945
0.010
 Why?
United States
1
2016
11763
0.010
 Why?
Retrospective Studies
1
2016
17540
0.010
 Why?
PAPPAS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (64)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_